• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21996 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive versus negative needleless connectors for central venous lines and peripheral lines: a review of the clinical effectiveness and guidelines
2004     Agency for Healthcare Research and Quality (AHRQ) Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)
1996     VA Technology Assessment Program (VATAP) Positron emission tomography
2001     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Positron emission tomography
2000     Medical Services Advisory Committee (MSAC) Positron emission tomography
1994     University HealthSystem Consortium (UHC) Positron emission tomography
2001     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Positron emission tomography - the economic efficacy
2000     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Positron emission tomography - the economic efficacy
2001     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography (FDG) for myocardial viability
2002     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography (FDG) for soft tissue sarcoma
2000     Norwegian Knowledge Centre for the Health Services (NOKC) Positron emission tomography (PET)
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Positron emission tomography (PET) - diagnostic and clinical use
2003     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Positron emission tomography (PET) - systematic review of efficacy in selective medical indications
2003     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Positron emission tomography (PET) - systematic review of efficacy in selective medical indications
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2013     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2010     HAYES, Inc. Positron emission tomography (PET) and combined positron emission tomography-computed tomography (PET-CT) for breast cancer detection
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011     HAYES, Inc. Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011     NIHR Health Technology Assessment programme Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2017     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2016     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2011     HAYES, Inc. Positron Emission Tomography (PET) for alzheimer's disease
2002     HAYES, Inc. Positron emission tomography (PET) for Alzheimer's disease (AD)
2007     HAYES, Inc. Positron emission tomography (PET) for alzheimer's disease (AD)
2005     HAYES, Inc. Positron emission tomography (PET) for assessing myocardial metabolism
2002     HAYES, Inc. Positron emission tomography (PET) for bone cancer
2003     HAYES, Inc. Positron emission tomography (PET) for breast cancer
2003     HAYES, Inc. Positron emission tomography (PET) for cardiac applications
2001     HAYES, Inc. Positron emission tomography (PET) for central nervous system (CNS) tumors
2000     HAYES, Inc. Positron emission tomography (PET) for colorectal cancer
2009     HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2006     ECRI Positron emission tomography (PET) for diagnosis and staging of lymphoma
2003     HAYES, Inc. Positron emission tomography (PET) for epilepsy
2004     Medical Services Advisory Committee (MSAC) Positron emission tomography (PET) for epilepsy
2004     HAYES, Inc. Positron emission tomography (PET) for Huntington's disease (HD)
2002     HAYES, Inc. Positron emission tomography (PET) for liver cancer
2002     HAYES, Inc. Positron emission tomography (PET) for lung cancer
2000     HAYES, Inc. Positron emission tomography (PET) for malignant lymphoma
2000     HAYES, Inc. Positron emission tomography (PET) for malignant melanoma
2014     HAYES, Inc. Positron Emission Tomography (PET) for metastatic melanoma
2009     HAYES, Inc. Positron Emission Tomography (PET) for monitoring and prognosis of lung cancer
2001     HAYES, Inc. Positron emission tomography (PET) for non-central nervous system head and neck tumors
2001     HAYES, Inc. Positron emission tomography (PET) for oesophageal cancer
2002     HAYES, Inc. Positron emission tomography (PET) for other malignancies
2001     HAYES, Inc. Positron emission tomography (PET) for ovarian cancer
2001     HAYES, Inc. Positron emission tomography (PET) for pancreatic cancer
2004     HAYES, Inc. Positron emission tomography (PET) for Parkinson's disease
2001     HAYES, Inc. Positron emission tomography (PET) for prostate cancer
2002     HAYES, Inc. Positron emission tomography (PET) for soft-tissue sarcoma
2005     HAYES, Inc. Positron emission tomography (PET) for stroke
2001     HAYES, Inc. Positron emission tomography (PET) for testicular cancer
2010     Medical Advisory Secretariat (MAS) Positron emission tomography (PET) for the assessment of myocardial viability
2003     HAYES, Inc. Positron emission tomography (PET) for thyroid cancer
2009     HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Positron emission tomography (PET) imaging in cancer management; HTA Advice 2: Positron emission tomography (PET) imaging in cancer management; Understanding HTBS Advice; Use of PET imaging for cancer in Scotland. Amendment to full report published July 2005.
2009     Belgian Health Care Knowledge Centre (KCE) Positron Emission Tomography (PET) in Belgium: an update
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) in cardiology. IPE-95/e (Public report)
2001     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Positron emission tomography (PET) in oncology in Catalonia: current state and proposal for monitorisation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2008     Medical Services Advisory Committee (MSAC) Positron emission tomography (PET) review: colorectal, melanoma and ovarian cancer
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) with 18FDG on clinical oncology. IPE-01/30 (Public report)
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Positron emission tomography (PET): diagnostic usefulness and indications
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Positron emission tomography (systematic review, primary research, expert panel, working group)
1998     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Positron emission tomography (systematic review, working group, expert panel)
2001     Medical Services Advisory Committee (MSAC) Positron emission tomography [Part 2(i)]
2001     Medical Services Advisory Committee (MSAC) Positron emission tomography [Part 2(ii)]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Positron emission tomography and computed tomographic imaging prior to radiotherapy for anal cancer
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Positron emission tomography and computed tomographic imaging prior to radiotherapy for lung cancer
2007     Andalusian Health Technology Assessment Area (AETSA) Positron Emission Tomography combined with Magnetic Resonance (PET/RM)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for cardiovascular disease: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2008     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)
2005     Medical Advisory Secretariat (MAS) Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis
2005     Belgian Health Care Knowledge Centre (KCE) Positron Emission Tomography in Belgium
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography in neurology and cardiology: a review of guidelines and recommendations
2001     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Positron emission tomography in Quebec
2020     NIHR Health Technology Assessment programme Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
1999     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography with fluordeoxyglucose (FDG-PET) in neurology. IPE-99/18 (Public report)
2017     HAYES, Inc. Positron emission tomography-computed tomography (PET-CT) for detection of primary site in neuroendocrine tumors of unknown origin
2004     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography, single photon emission computed tomography, computed tomography, functional magnetic resonance imaging, and magnetic resonance spectroscopy and for the diagnosis and management of Alzheimer's dementia
1998     VA Technology Assessment Program (VATAP) Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease
1999     NIHR Health Technology Assessment programme Positron emission tomography: establishing priorities for health technology assessment
1999     VA Technology Assessment Program (VATAP) Positron emission tomography: experience with PET and synthesis of the evidence (INAHTA Joint Project)
2000     Andalusian Health Technology Assessment Area (AETSA) Positron emission tomography: research synthesis on effectiveness in specific indications - systematic review
2013     NIHR Health Technology Assessment programme Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Positron emission tomography/magnetic resonance imaging (PET/MRI) in cancer
2003     ECRI Positron imaging for diagnosis and staging of breast cancer
2002     ECRI Positron imaging for differentiation of recurrent brain tumor from radionecrosis: update
2022     NIHR Health Technology Assessment programme POSNOC - POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: A randomised controlled trial of axillary treatment in women with early stage breast cancer who have metastases in one or two sentinel nodes
1994     TNO Possibilities of a technology assessment regarding extramural technology: technological products and services which contribute to independent living of (elderly, disabled and chronically ill) people
2009     Penn Medicine Center for Evidence-based Practice (CEP) Post operative use of COX-2 inhibitors in bone surgery
2015     Institute of Health Economics (IHE) Post policy implementation review (PPIR) of rapid fetal fibronectin testing for preterm labour in Alberta
2013     NIHR Horizon Scanning Centre (NIHR HSC) POST-C saliva test for suspected oral cancer
2012     Penn Medicine Center for Evidence-based Practice (CEP) Post-discharge telephone calls to reduce hospital readmissions
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Post-introduction observation of health technologies. A methodological guideline
2005     Agency for Healthcare Research and Quality (AHRQ) Post-myocardial infarction depression
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-operative cerebrospinal fluid removal: guidelines
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Post-polio syndrome: revision of the literature, situation in Spain and possible performance lines (public report). CISNS-02/07
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-surgical surveillance for surgical site infections: guidelines